Who Owns Alaunos Therapeutics Stock?
NASDAQ: TCRTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.8199 +4.34%
Ownership breakdown
- Held by institutions
- 4.23%
- Held by insiders
- 13.28%
- Institutional holders
- 32
- Institutions 4.2%
- Insiders 13.3%
- Public and other 82.5%
Who owns Alaunos Therapeutics stock?
Institutional investors own about 4.2% of Alaunos Therapeutics's shares, spread across 32 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 13.28% of TCRT.
The largest institutional holders are Blackrock Inc. (0.84%), Geode Capital Management, LLC (0.76%) and Vanguard Fiduciary Trust Co (0.61%). Together, the top 10 institutions control 3.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their TCRT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TCRT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 21.35K | 0.84% | 0.0% |
| Geode Capital Management, LLC | 19.36K | 0.76% | -14.2% |
| Vanguard Fiduciary Trust Co | 15.50K | 0.61% | 0.0% |
| Vanguard Capital Management LLC | 14.06K | 0.55% | 0.0% |
| Citadel Advisors Llc | 11.87K | 0.47% | +12.8% |
| Osaic Holdings Inc. | 1.73K | 0.07% | -2.7% |
| Tower Research Capital LLC (TRC) | 1.62K | 0.06% | +2.4% |
| Arax Advisory Partners | 1.22K | 0.05% | +100.0% |
| UBS Group AG | 992 | 0.04% | -56.4% |
| Morgan Stanley | 836 | 0.03% | +28.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TCRT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 14.06K | 0.55% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 12.17K | 0.48% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.38K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.32K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.12K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Alaunos Therapeutics?
Blackrock Inc. is the largest institutional shareholder of TCRT, owning 0.84% of shares outstanding (21.35K shares) as of its latest 13F filing.
What percentage of Alaunos Therapeutics is owned by institutions?
Institutions own about 4.2% of TCRT shares and 4.9% of the public float.
How much of Alaunos Therapeutics do insiders own?
Insiders, such as officers and directors, own about 13.28% of TCRT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.